Interaction of CAP18-derived peptides with membranes made from endotoxins or phospholipids.
about
The host defense peptide cathelicidin is required for NK cell-mediated suppression of tumor growthStructure of the lipid A-inner core region and biological activity of Plesiomonas shigelloides O54 (strain CNCTC 113/92) lipopolysaccharide.Calcium adsorption and displacement: characterization of lipid monolayers and their interaction with membrane-active peptides/proteins.Human antimicrobial peptide LL-37 is present in atherosclerotic plaques and induces death of vascular smooth muscle cells: a laboratory study.Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria.Gut microbiota. Antimicrobial peptide resistance mediates resilience of prominent gut commensals during inflammation.Comparative Evaluation of the Antimicrobial Activity of Different Antimicrobial Peptides against a Range of Pathogenic BacteriaBH3 domain-independent apolipoprotein L1 toxicity rescued by BCL2 prosurvival proteins.Effects of antimicrobial peptides on methanogenic archaea.Bacterial Evasion of Host Antimicrobial Peptide DefensesAntimicrobial peptides in human skin disease.Antimicrobial peptides, skin infections, and atopic dermatitisComparison between the behavior of different hydrophobic peptides allowing membrane anchoring of proteins.Inner field compensation as a tool for the characterization of asymmetric membranes and Peptide-membrane interactions.Enhancement of endotoxin neutralization by coupling of a C12-alkyl chain to a lactoferricin-derived peptide.Immunogenic properties of the human gut-associated archaeon Methanomassiliicoccus luminyensis and its susceptibility to antimicrobial peptides.Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens.
P2860
Q30933550-30D6D114-47FA-4B4B-827E-C279F68A2A07Q33234389-31E448DF-7DE1-4365-8153-7C08D7C7A433Q33242093-875AE211-BFF8-4CF9-B78D-7EFEF885F93DQ33267198-B571EF05-11AF-40D7-939D-007603B5F4C2Q34721515-DEF36548-BA9E-4E8A-BB65-048B593A7E54Q35300228-F9E14064-B9EE-4FC8-B37C-197000340036Q35866086-87AC78E8-E545-49A0-8455-48C10E02BD2EQ36017640-C564D7AF-DADA-4367-95D4-E29008202177Q36171501-1C0C73CA-5930-40DA-853D-3CE07A36106CQ36720179-9BE0C8EB-8A16-47B6-919D-2CD161CD2D51Q37034707-83F44655-C537-4174-97C0-CC562FD0F42FQ37213664-44F6BCA6-EE25-4280-BB13-B93A93B701BAQ38190250-E51EBAAD-6423-4B1E-8ACC-CD9285BE3312Q40273154-1627E80E-5641-46BD-892B-AB1E10213277Q41921532-6629AC12-1B2B-413F-A053-413A6190469BQ42370752-1F92D7B3-FFF7-4D56-8DC2-4559913C488DQ54444333-7E394A61-1588-4D79-A821-F622201DEEC4
P2860
Interaction of CAP18-derived peptides with membranes made from endotoxins or phospholipids.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Interaction of CAP18-derived p ...... m endotoxins or phospholipids.
@en
type
label
Interaction of CAP18-derived p ...... m endotoxins or phospholipids.
@en
prefLabel
Interaction of CAP18-derived p ...... m endotoxins or phospholipids.
@en
P2093
P2860
P1433
P1476
Interaction of CAP18-derived p ...... m endotoxins or phospholipids.
@en
P2093
P2860
P304
P356
10.1016/S0006-3495(01)76259-5
P407
P577
2001-06-01T00:00:00Z